EVH logo

Evolent Health, Inc. (EVH) EBITDA

annual EBITDA:

$125.50M-$28.70M(-18.61%)
December 31, 2024

Summary

  • As of today (September 16, 2025), EVH annual EBITDA is $125.50 million, with the most recent change of -$28.70 million (-18.61%) on December 31, 2024.
  • During the last 3 years, EVH annual EBITDA has risen by +$82.88 million (+194.49%).
  • EVH annual EBITDA is now -18.61% below its all-time high of $154.20 million, reached on December 31, 2023.

Performance

EVH EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

quarterly EBITDA:

$27.25M+$254.00K(+0.94%)
June 30, 2025

Summary

  • As of today (September 16, 2025), EVH quarterly EBITDA is $27.25 million, with the most recent change of +$254.00 thousand (+0.94%) on June 30, 2025.
  • Over the past year, EVH quarterly EBITDA has dropped by -$13.19 million (-32.61%).
  • EVH quarterly EBITDA is now -35.23% below its all-time high of $42.08 million, reached on March 31, 2023.

Performance

EVH quarterly EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

TTM EBITDA:

$101.59M-$13.19M(-11.49%)
June 30, 2025

Summary

  • As of today (September 16, 2025), EVH TTM EBITDA is $101.59 million, with the most recent change of -$13.19 million (-11.49%) on June 30, 2025.
  • Over the past year, EVH TTM EBITDA has dropped by -$52.45 million (-34.05%).
  • EVH TTM EBITDA is now -37.37% below its all-time high of $162.20 million, reached on December 31, 2023.

Performance

EVH TTM EBITDA Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Range

Earnings dates

OtherEVHincome statement metrics

EBITDA Formula

EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization

EVH EBITDA Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-18.6%-32.6%-34.0%
3 y3 years+194.5%+85.4%+63.5%
5 y5 years+445.0%+154.5%+368.9%

EVH EBITDA Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-year-18.6%+194.5%-35.2%+85.4%-37.4%+63.5%
5 y5-year-18.6%+445.0%-35.2%+240.3%-37.4%+368.9%
alltimeall time-18.6%+314.6%-35.2%+192.5%-37.4%+272.7%

EVH EBITDA History

DateAnnualQuarterlyTTM
Jun 2025
-
$27.25M(+0.9%)
$101.59M(-11.5%)
Mar 2025
-
$27.00M(-9.7%)
$114.78M(-6.8%)
Dec 2024
$125.50M(-18.6%)
$29.91M(+71.5%)
$123.11M(-5.8%)
Sep 2024
-
$17.43M(-56.9%)
$130.65M(-15.2%)
Jun 2024
-
$40.44M(+14.5%)
$154.04M(-0.9%)
Mar 2024
-
$35.33M(-5.6%)
$155.45M(-4.2%)
Dec 2023
$154.20M(+61.8%)
$37.45M(-8.3%)
$162.20M(+8.5%)
Sep 2023
-
$40.83M(-2.5%)
$149.45M(+13.9%)
Jun 2023
-
$41.85M(-0.5%)
$131.24M(+26.1%)
Mar 2023
-
$42.08M(+70.4%)
$104.09M(+28.7%)
Dec 2022
$95.31M(+123.6%)
$24.69M(+9.2%)
$80.89M(+7.1%)
Sep 2022
-
$22.62M(+53.9%)
$75.50M(+21.5%)
Jun 2022
-
$14.70M(-22.1%)
$62.14M(+2.4%)
Mar 2022
-
$18.88M(-2.2%)
$60.68M(+19.2%)
Dec 2021
$42.62M(+41.9%)
$19.30M(+108.4%)
$50.93M(+6.8%)
Sep 2021
-
$9.26M(-30.1%)
$47.67M(+2.7%)
Jun 2021
-
$13.24M(+45.0%)
$46.41M(+5.8%)
Mar 2021
-
$9.13M(-43.1%)
$43.88M(+8.9%)
Dec 2020
$30.02M(-182.5%)
$16.04M(+100.2%)
$40.30M(+24.7%)
Sep 2020
-
$8.01M(-25.2%)
$32.30M(+49.1%)
Jun 2020
-
$10.71M(+93.2%)
$21.66M(-972.5%)
Mar 2020
-
$5.54M(-31.1%)
-$2.48M(-91.0%)
Dec 2019
-$36.37M
$8.05M(-405.9%)
-$27.50M(+61.7%)
Sep 2019
-
-$2.63M(-80.4%)
-$17.01M(-770.1%)
DateAnnualQuarterlyTTM
Jun 2019
-
-$13.44M(-31.0%)
$2.54M(-92.9%)
Mar 2019
-
-$19.48M(-205.0%)
$35.87M(-48.9%)
Dec 2018
$68.22M(-383.4%)
$18.55M(+9.6%)
$70.16M(+38.7%)
Sep 2018
-
$16.91M(-15.0%)
$50.60M(+70.5%)
Jun 2018
-
$19.89M(+34.3%)
$29.69M(-3724.7%)
Mar 2018
-
$14.81M(-1558.0%)
-$819.00K(-96.9%)
Dec 2017
-$24.07M(-58.8%)
-$1.02M(-74.6%)
-$26.67M(-51.6%)
Sep 2017
-
-$4.00M(-62.3%)
-$55.12M(-6.3%)
Jun 2017
-
-$10.61M(-3.9%)
-$58.81M(+2.8%)
Mar 2017
-
-$11.04M(-62.5%)
-$57.21M(-0.1%)
Dec 2016
-$58.48M(+63.3%)
-$29.46M(+283.0%)
-$57.28M(+47.3%)
Sep 2016
-
-$7.69M(-14.7%)
-$38.88M(-14.3%)
Jun 2016
-
-$9.02M(-18.8%)
-$45.38M(-3.3%)
Mar 2016
-
-$11.11M(+0.4%)
-$46.91M(+31.0%)
Dec 2015
-$35.81M(<-9900.0%)
-$11.06M(-22.0%)
-$35.81M(+44.7%)
Sep 2015
-
-$14.19M(+34.4%)
-$24.75M(+134.4%)
Jun 2015
-
-$10.55M(<-9900.0%)
-$10.55M(<-9900.0%)
Mar 2015
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2014
$0.00(-100.0%)
$0.00(0.0%)
$0.00(0.0%)
Sep 2014
-
$0.00(0.0%)
$0.00(0.0%)
Jun 2014
-
$0.00(0.0%)
$0.00(0.0%)
Mar 2014
-
$0.00(0.0%)
$0.00(0.0%)
Dec 2013
-$19.95M(+5.5%)
-
-
Dec 2013
-
$0.00
$0.00
Dec 2012
-$18.91M
-
-

FAQ

  • What is Evolent Health, Inc. annual EBITDA?
  • What is the all time high annual EBITDA for Evolent Health, Inc.?
  • What is Evolent Health, Inc. annual EBITDA year-on-year change?
  • What is Evolent Health, Inc. quarterly EBITDA?
  • What is the all time high quarterly EBITDA for Evolent Health, Inc.?
  • What is Evolent Health, Inc. quarterly EBITDA year-on-year change?
  • What is Evolent Health, Inc. TTM EBITDA?
  • What is the all time high TTM EBITDA for Evolent Health, Inc.?
  • What is Evolent Health, Inc. TTM EBITDA year-on-year change?

What is Evolent Health, Inc. annual EBITDA?

The current annual EBITDA of EVH is $125.50M

What is the all time high annual EBITDA for Evolent Health, Inc.?

Evolent Health, Inc. all-time high annual EBITDA is $154.20M

What is Evolent Health, Inc. annual EBITDA year-on-year change?

Over the past year, EVH annual EBITDA has changed by -$28.70M (-18.61%)

What is Evolent Health, Inc. quarterly EBITDA?

The current quarterly EBITDA of EVH is $27.25M

What is the all time high quarterly EBITDA for Evolent Health, Inc.?

Evolent Health, Inc. all-time high quarterly EBITDA is $42.08M

What is Evolent Health, Inc. quarterly EBITDA year-on-year change?

Over the past year, EVH quarterly EBITDA has changed by -$13.19M (-32.61%)

What is Evolent Health, Inc. TTM EBITDA?

The current TTM EBITDA of EVH is $101.59M

What is the all time high TTM EBITDA for Evolent Health, Inc.?

Evolent Health, Inc. all-time high TTM EBITDA is $162.20M

What is Evolent Health, Inc. TTM EBITDA year-on-year change?

Over the past year, EVH TTM EBITDA has changed by -$52.45M (-34.05%)
On this page